MedPath

Oxacillin

Oxacillin for Injection, USP

Approved
Approval ID

9f0f30cb-ade2-4690-b63d-b069b8e4ed89

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 5, 2020

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 796852890

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

oxacillin sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25021-163
Application NumberANDA091245
Product Classification
M
Marketing Category
C73584
G
Generic Name
oxacillin sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 5, 2020
FDA Product Classification

INGREDIENTS (2)

oxacillin sodiumActive
Quantity: 10 g in 100 mL
Code: G0V6C994Q5
Classification: ACTIM
sodium phosphate, dibasic, unspecified formInactive
Code: GR686LBA74
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxacillin - FDA Drug Approval Details